Association of fludarabin, cytarabine, and fractioned gemtuzumab followed by hematopoietic stem cell transplantation for first-line refractory acute myeloid leukemia in children: A single-center experience. [electronic resource]
Producer: 20200817Description: e28305 p. digitalISSN:- 1545-5017
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Child
- Combined Modality Therapy
- Cytarabine -- administration & dosage
- Drug Resistance, Neoplasm
- Female
- Follow-Up Studies
- Gemtuzumab -- administration & dosage
- Hematopoietic Stem Cell Transplantation -- mortality
- Humans
- Leukemia, Myeloid, Acute -- pathology
- Male
- Neoplasm Recurrence, Local -- pathology
- Prognosis
- Retrospective Studies
- Salvage Therapy
- Survival Rate
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.